Joseph M. Brutico
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Joseph M. Brutico has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Emma E. Johnson
Rothman Orthopaedic Institute, Philadelphia, Pennsylvania, USA
2 shared publications - Sommer Hammoud
Rothman Orthopaedics, Thomas Jefferson University Hospitals
2 shared publications Anthony G. Brutico
1 shared publication- Anthony G. Brutico
Principal Investigator, Geisinger Community Medical Center, 1800 MULBERRY STREET, SCRANTON, PA 18510, Ph: 570-335-2862
1 shared publication David Chromey
1 shared publication- Ellianne M. Nasser
Secondary Investigator, Geisinger Community Medical Center, 1800 MULBERRY STREET, SCRANTON, PA 18510, Ph: 570-479-8595
1 shared publication
Latest Publications
- Open Access
- 1 July 2023
- Published by SAGE Publications in Orthopaedic Journal of Sports Medicine
- Vol. 11 (7_suppl3)
Paper 07: Postoperative Opioid Usage and Disposal Strategies Following Outpatient Arthroscopic Sports Medicine Procedures: A Prospective Observational Study
Objectives: While several studies have noted that patients are routinely over-prescribed opioids, few have reported usage following arthroscopic surgery. Nearly 2 million arthroscopic procedures are performed annually, and one study estimates that opioids are prescribed in excess in 88% of patients recovering from arthroscopic knee surgery. Such surplus of postoperative opioid prescription creates a conundrum, as many patients do not appropriately dispose of unused opioid pills, and the majority of recreational opioid users obtain these medications from friends or family. The objectives of this study were to determine opioid consumption, utilization of total prescription, and allocation for unused opioids following five common arthroscopic surgeries. Methods: This study is a prospective trial enrolling patients between the ages of 15-40 who were scheduled to undergo elective anterior cruciate ligament (ACL) reconstruction, labral repair of the hip or shoulder, meniscectomy, or meniscal repair. Patients were prescribed either 5-325 hydrocodone-acetaminophen or 5-325 oxycodone-acetaminophen based on surgeon preference. Patients completed a daily opioid usage survey during the 2-week postoperative period. In addition, patients completed a survey on postoperative day 21 inquiring about continued opioid use and medication disposal, if applicable. Opioid medication consumption was converted to morphine milliequivalents (MME) where one 5 mg oxycodone pill is equivalent to 7.5 MME and one 5 mg hydrocodone pill is equivalent to 5.0 MME. T-tests or Mann-Whitney U tests were used to calculate differences between continuous data. Chi-Square or Fisher’s Exact were used for categorical data. Results: Of the 200 patients enrolled in the study, 100 (50%) underwent ACL reconstruction, 26 (13%) underwent arthroscopic hip labral repair, 37 (19%) underwent arthroscopic shoulder labral repair, 23 (12%) underwent meniscectomy, and 14 (7%) underwent meniscal repair. The mean MME consumption in the 14 days following each procedure was calculated: ACL reconstruction (88.9), hip arthroscopy (84.8), shoulder arthroscopy (55.5), meniscectomy (24.3), and meniscal repair (31.2). This corresponded to a utilization rate of 40.4%, 36.5%, 40.7%, 37.4%, and 34.6% respectively (Table 1). Mean MME consumption was greatest on postoperative day 1 in all procedures, and only 6.6% of patients reported continued opioid use in the third postoperative week. Of the 141 patients available for follow up at 3 weeks, 113 reported having opioid medication remaining. Of the patients with remaining medication, 25.6% intended to keep their medication for future use (Figure 2). Conclusions: The results of our study indicate that patients who undergo the aforementioned arthroscopic procedures consume a mean of 70 MME in the 2-week postoperative period, translating into an average of 9-14 pills consumed, depending on medication prescribed. Few patients reported requiring opioid medication after 2 weeks postoperatively. Patients undergoing ACL reconstruction and hip labral repairs consumed the highest MME, followed by shoulder labral repair patients who consumed approximately 3 times more opioids than primary meniscal procedures. Approximately 65% of total opioids prescribed went unused, and over one fourth of patients intended to keep their remaining medication for future usage. [Table: see text]
- 1 July 2023
- Published by SAGE Publications in Orthopaedic Journal of Sports Medicine
- Vol. 11 (7_suppl3)
Open AccessPaper 07: Postoperative Opioid Usage and Disposal Strategies Following Outpatient Arthroscopic Sports Medicine Procedures: A Prospective Observational Study
Objectives: While several studies have noted that patients are routinely over-prescribed opioids, few have reported usage following arthroscopic surgery. Nearly 2 million arthroscopic procedures are performed annually, and one study estimates that opioids are prescribed in excess in 88% of patients recovering from arthroscopic knee surgery. Such surplus of postoperative opioid prescription creates a conundrum, as many patients do not appropriately dispose of unused opioid pills, and the majority of recreational opioid users obtain these medications from friends or family. The objectives of this study were to determine opioid consumption, utilization of total prescription, and allocation for unused opioids following five common arthroscopic surgeries. Methods: This study is a prospective trial enrolling patients between the ages of 15-40 who were scheduled to undergo elective anterior cruciate ligament (ACL) reconstruction, labral repair of the hip or shoulder, meniscectomy, or meniscal repair. Patients were prescribed either 5-325 hydrocodone-acetaminophen or 5-325 oxycodone-acetaminophen based on surgeon preference. Patients completed a daily opioid usage survey during the 2-week postoperative period. In addition, patients completed a survey on postoperative day 21 inquiring about continued opioid use and medication disposal, if applicable. Opioid medication consumption was converted to morphine milliequivalents (MME) where one 5 mg oxycodone pill is equivalent to 7.5 MME and one 5 mg hydrocodone pill is equivalent to 5.0 MME. T-tests or Mann-Whitney U tests were used to calculate differences between continuous data. Chi-Square or Fisher’s Exact were used for categorical data. Results: Of the 200 patients enrolled in the study, 100 (50%) underwent ACL reconstruction, 26 (13%) underwent arthroscopic hip labral repair, 37 (19%) underwent arthroscopic shoulder labral repair, 23 (12%) underwent meniscectomy, and 14 (7%) underwent meniscal repair. The mean MME consumption in the 14 days following each procedure was calculated: ACL reconstruction (88.9), hip arthroscopy (84.8), shoulder arthroscopy (55.5), meniscectomy (24.3), and meniscal repair (31.2). This corresponded to a utilization rate of 40.4%, 36.5%, 40.7%, 37.4%, and 34.6% respectively (Table 1). Mean MME consumption was greatest on postoperative day 1 in all procedures, and only 6.6% of patients reported continued opioid use in the third postoperative week. Of the 141 patients available for follow up at 3 weeks, 113 reported having opioid medication remaining. Of the patients with remaining medication, 25.6% intended to keep their medication for future use (Figure 2). Conclusions: The results of our study indicate that patients who undergo the aforementioned arthroscopic procedures consume a mean of 70 MME in the 2-week postoperative period, translating into an average of 9-14 pills consumed, depending on medication prescribed. Few patients reported requiring opioid medication after 2 weeks postoperatively. Patients undergoing ACL reconstruction and hip labral repairs consumed the highest MME, followed by shoulder labral repair patients who consumed approximately 3 times more opioids than primary meniscal procedures. Approximately 65% of total opioids prescribed went unused, and over one fourth of patients intended to keep their remaining medication for future usage. [Table: see text]
- Open Access
- 1 September 2022
- Published by SAGE Publications in Orthopaedic Journal of Sports Medicine
- Vol. 10 (9)
Open Repair of Complete Proximal Hamstring Avulsions in Workers’ Compensation Patients
Background: Several studies have reported excellent results after surgical repair of proximal hamstring avulsions. However, the effect on these patients of receiving workers’ compensation has not yet been explored. Hypothesis: Workers’ compensation patients undergoing proximal hamstring repair of complete tears will have similar outcomes when compared with a matched control group of non–workers’ compensation patients. Study Design: Cohort study; Level of evidence, 3. Methods: Workers’ compensation patients who underwent complete proximal hamstring avulsion open repair between 2010 and 2019 were identified (WC group). A control group was matched by age (±3 years), sex, and body mass index (BMI; ±3). Demographics and patient-reported outcome measures were compared, including standard and custom Marx activity rating scale (MARS), standard and custom lower extremity functional scale (LEFS), and visual analog scale (VAS) for pain. Rate and time to return to work were recorded. Results: The WC group was composed of 20 patients (8 men, 12 women) with a mean age of 52.3 years and BMI of 32.4. The 20 matched controls (8 men, 12 women) who underwent repair had a mean age of 50.6 years and a mean BMI of 31.2. There was no difference between the groups regarding age ( P = .924), sex ( P > .999), or BMI ( P = .330). The WC group reported similar mean MARS (3.3 vs 5.4; P = .174), custom MARS (87.5 vs 97.0; P = .215), and VAS pain (3.3 vs 3.8; P = .698) scores compared with controls. However, the WC group had significantly lower standard LEFS (69.1 vs 94.1; P < .001) and custom LEFS (62.3 vs 87.9; P < .001) scores, returned to work at a lower rate (70.0% vs 94.1%; P = .039), and required more time to return to work after repair (4.3 vs 3.5 months; P = .029) compared with controls. Conclusion: Workers’ compensation patients who underwent open proximal hamstring repair for complete avulsions experienced inferior patient-reported outcomes, required more time to return to work, and returned to work at a lower rate than a matched control group.
- 1 September 2022
- Published by SAGE Publications in Orthopaedic Journal of Sports Medicine
- Vol. 10 (9)
Open AccessOpen Repair of Complete Proximal Hamstring Avulsions in Workers’ Compensation Patients
Background: Several studies have reported excellent results after surgical repair of proximal hamstring avulsions. However, the effect on these patients of receiving workers’ compensation has not yet been explored. Hypothesis: Workers’ compensation patients undergoing proximal hamstring repair of complete tears will have similar outcomes when compared with a matched control group of non–workers’ compensation patients. Study Design: Cohort study; Level of evidence, 3. Methods: Workers’ compensation patients who underwent complete proximal hamstring avulsion open repair between 2010 and 2019 were identified (WC group). A control group was matched by age (±3 years), sex, and body mass index (BMI; ±3). Demographics and patient-reported outcome measures were compared, including standard and custom Marx activity rating scale (MARS), standard and custom lower extremity functional scale (LEFS), and visual analog scale (VAS) for pain. Rate and time to return to work were recorded. Results: The WC group was composed of 20 patients (8 men, 12 women) with a mean age of 52.3 years and BMI of 32.4. The 20 matched controls (8 men, 12 women) who underwent repair had a mean age of 50.6 years and a mean BMI of 31.2. There was no difference between the groups regarding age ( P = .924), sex ( P > .999), or BMI ( P = .330). The WC group reported similar mean MARS (3.3 vs 5.4; P = .174), custom MARS (87.5 vs 97.0; P = .215), and VAS pain (3.3 vs 3.8; P = .698) scores compared with controls. However, the WC group had significantly lower standard LEFS (69.1 vs 94.1; P < .001) and custom LEFS (62.3 vs 87.9; P < .001) scores, returned to work at a lower rate (70.0% vs 94.1%; P = .039), and required more time to return to work after repair (4.3 vs 3.5 months; P = .029) compared with controls. Conclusion: Workers’ compensation patients who underwent open proximal hamstring repair for complete avulsions experienced inferior patient-reported outcomes, required more time to return to work, and returned to work at a lower rate than a matched control group.
- 1 May 2022
- Published by Elsevier in The Journal of Foot and Ankle Surgery
- Vol. 61 (3) , 542-550
Operative Ankle Fractures in Complicated Diabetes: Outcomes of Prolonged Non-Weightbearing
- 1 May 2022
- Published by Elsevier in The Journal of Foot and Ankle Surgery
- Vol. 61 (3) , 542-550
Operative Ankle Fractures in Complicated Diabetes: Outcomes of Prolonged Non-Weightbearing
- Open Access
- 1 January 2021
- Published by Elsevier in Foot & Ankle Surgery: Techniques, Reports & Cases
- Vol. 1 (2)
Myoepithelioma of the ankle: A case report
- 1 January 2021
- Published by Elsevier in Foot & Ankle Surgery: Techniques, Reports & Cases
- Vol. 1 (2)
Open AccessMyoepithelioma of the ankle: A case report